Universal Beteiligungs und Servicegesellschaft mbH Acquires 53,088 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH raised its stake in GE HealthCare by 12.9%, buying 53,088 shares to hold 463,722 shares worth about $38.37 million (≈0.10% of the company).
• GE HealthCare beat quarterly estimates, reporting $1.44 EPS vs $1.40 expected and $5.70B revenue vs $5.60B expected, and set FY2026 guidance of $4.95–$5.15 EPS (analysts expect ~5 EPS).
• Institutional ownership stands at 82.06%, with major funds like Dodge & Cox and Capital Research materially increasing their positions, signaling substantial institutional accumulation.

Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 12.9% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 463,722 shares of the company's stock after acquiring an additional 53,088 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.10% of GE HealthCare Technologies worth $38,369,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently bought and sold shares of the business. Dodge & Cox grew its position in GE HealthCare Technologies by 16.8% in the 3rd quarter. Dodge & Cox now owns 27,517,311 shares of the company's stock valued at $2,066,550,000 after acquiring an additional 3,949,361 shares during the last quarter. Capital Research Global Investors lifted its holdings in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock worth $1,875,400,000 after buying an additional 4,998,154 shares during the period. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of GE HealthCare Technologies by 17.1% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company's stock worth $633,271,000 after buying an additional 1,232,828 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company's stock worth $402,647,000 after buying an additional 438,439 shares during the period. Finally, Van ECK Associates Corp lifted its holdings in shares of GE HealthCare Technologies by 3.2% in the 3rd quarter. Van ECK Associates Corp now owns 4,497,827 shares of the company's stock worth $337,787,000 after buying an additional 139,404 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 2.1%

Shares of NASDAQ GEHC opened at $69.89 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The stock has a market capitalization of $31.89 billion, a P/E ratio of 15.33, a price-to-earnings-growth ratio of 1.57 and a beta of 1.17. GE HealthCare Technologies Inc. has a 1-year low of $64.77 and a 1-year high of $89.77. The business has a fifty day moving average price of $74.88 and a 200 day moving average price of $77.82.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company had revenue of $5.70 billion during the quarter, compared to analysts' expectations of $5.60 billion. During the same period last year, the business posted $1.45 earnings per share. The firm's revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts expect that GE HealthCare Technologies Inc. will post 5 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.07%.

Analyst Upgrades and Downgrades

GEHC has been the subject of several research reports. Weiss Ratings reiterated a "hold (c+)" rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Barclays upped their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Friday, February 6th. UBS Group cut GE HealthCare Technologies from a "neutral" rating to a "sell" rating and upped their target price for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Morgan Stanley upped their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an "equal weight" rating in a report on Wednesday, February 4th. Finally, Evercore upped their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an "outperform" rating in a report on Thursday, February 5th. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $89.77.

GE HealthCare Technologies Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.